Stem Cells and Regenerative Medicine Centre, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, Karnataka, India.
J Cell Biochem. 2021 Apr;122(3-4):349-366. doi: 10.1002/jcb.29863. Epub 2020 Nov 2.
Cancer stem cells (CSCs) are quiescent and self-renewing, having low levels of reactive oxygen species (ROS), and are responsible for cancer recurrence after chemotherapy and radiotherapy. However, the interplay between the ROS production and scavenging from the oxidative stress has never been studied in breast CSCs. In this present study, we have investigated the cellular energetics of two triple-negative breast cancer stem cells (MDA-MB-231 and MDA-MB-468) treated with two pharmacological doses of vitamin C (10 and 20 mM) that generated ROS. Our results indicate a differential behavior of ROS scavenging by both the CSCs. MDA-MB-468 CSCs exhibited higher resistance to ROS induced damage owing to the higher antioxidant activity, lower mitochondrial damage, and less decrease in membrane potential (ΔΨ ) as compared with MDA-MB-231 CSCs. Moreover, MDA-MB-231 CSCs exhibited an intrinsic apoptosis pathway by activating the cytochrome c, caspase-9, 3, 7, and cleaved PARP upon treatment with vitamin C. This data suggests a possible strategy for targeting breast CSCs using vitamin C. Taken together, the CSCs from MDA-MB-231 could be easily targeted by high/pharmacological doses of vitamin C (≥20 mM) thereby indicating a less robust internal antioxidant machinery.
癌症干细胞(CSCs)处于静止和自我更新状态,具有低水平的活性氧物种(ROS),并且是化疗和放疗后癌症复发的原因。然而,ROS 产生和氧化应激清除之间的相互作用从未在乳腺 CSCs 中研究过。在本研究中,我们研究了两种三阴性乳腺癌干细胞(MDA-MB-231 和 MDA-MB-468)在两种药理剂量的维生素 C(10 和 20 mM)作用下的细胞能量学,这些剂量会产生 ROS。我们的结果表明,两种 CSCs 对 ROS 清除的表现出不同的行为。与 MDA-MB-231 CSCs 相比,MDA-MB-468 CSCs 由于具有更高的抗氧化活性、更低的线粒体损伤和更低的膜电位(ΔΨ)下降,因此对 ROS 诱导的损伤表现出更高的抵抗力。此外,MDA-MB-231 CSCs 在受到维生素 C 处理后通过激活细胞色素 c、半胱天冬酶-9、3、7 和裂解的 PARP 来激活内在的细胞凋亡途径。这些数据表明,使用维生素 C 靶向乳腺 CSCs 可能是一种可行的策略。总之,来自 MDA-MB-231 的 CSCs 可以很容易地被高/药理剂量的维生素 C(≥20 mM)靶向,这表明其内部抗氧化机制不够强大。